Leflunomide is an immunomodulatory agent used in the therapy of rheumatoid arthritis and psoriatic arthritis
Other
C12H9F3N2O2
29420090
3 Years
Other
Dry Place
75706-12-6
Leflunomide
Medicine Grade
Powder
270.21 Kilograms (kg)
Antipyretic Analgesics and NSAIDs
Leflunomide Api Trade Information
Letter of Credit (L/C), Letter of Credit at Sight (Sight L/C), Cash Advance (CA), Cash in Advance (CID)
2 Week
Yes
Free samples are available
HDPE drums
Australia, North America, South America, Eastern Europe, Western Europe, Middle East, Africa, Central America, Asia
Product Description
Leflunomide is an immunomodulatory agent used in the therapy of rheumatoid arthritis and psoriatic arthritis. Leflunomide therapy is associated with frequent elevations in serum aminotransferase levels and with rare instances of clinically apparent acute liver injury which can be severe and even fatal
Leflunomide is a derivative of isoxazole used for its immunosuppressive and anti-inflammatory properties. As a prodrug, leflunomide is converted to an active metabolite, A77 1726, which blocks dihydroorotate dehydrogenase, a key enzyme of de novo pyrimidine synthesis, thereby preventing the expansion of activated T lymphocytes. This agent also inhibits various protein tyrosine kinases, such as protein kinase C (PKC), thereby inhibiting cell proliferation. (NCI04)
We are exporting in the countries such as Afghanistan, Algeria, Argentina, Bolivia, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, El Salvador, Guatemala, Indonesia, Iran, Jordan, Morocco, Panama, South Korea, Taiwan, Turkey, Uruguay, Vietnam and Yemen.
Get in touch with us
RFQ Request For Quotation
Get Quotes For Your Buying Requirement. Tell Suppliers What You Need.